Molina Healthcare's Issues Aren't Permanent, JPMorgan Says Amid Upgrade


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Molina Healthcare, Inc. (NYSE:MOH) and CEO Joe Zubretsky made quite an impression at the recent JPMorgan Healthcare conference, and Wall Street took notice.

The Analyst

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

JPMorgan analyst Gary Taylor upgraded Molina stock from Neutral to Overweight and raised his price target from $65 to $103.

The Thesis

Zubretsky’s plan of getting back to the basics by implementing “managed care 101” contracting may be exactly what the company needs.

“Zubretsky did not provide financial guidance, but did provide a comprehensive overview of operational opportunities while suggesting that he ‘would not be happy’ if material margin recovery towards industry peers took as long as three years,” Taylor wrote in a Tuesday note.


Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.


Taylor said Molina should be able to expand pretax margins to levels approaching those of competitors Centene Corp (NYSE:CNC) and WellCare Health Plans, Inc. (NYSE:WCG).

JPMorgan has raised its earnings estimates for 2017, 2018 and 2019 from $0.00, $2.00 and $3.00, respectively, to 88 cents, $4.58 and $6.03. The firm anticipates after tax margins of 1.3 percent in 2018 and 2.0 percent in 2019 after factoring in tailwinds from tax reform. JPMorgan expects after-tax margins of 2.0 percent in 2018 and 2.2 percent in 2019 from Centene and WellCare.

JPMorgan’s new price target represents a risk-adjusted 17.0 times earnings multiple on its 2019 EPS estimate.

Price Action

Molina stock jumped 5 percent Tuesday morning following the upgrade. The stock is now up 54 percent in the past year.

Related Links:

Key Takeaways From The J.P. Morgan Healthcare Conference

3 Likely Health Care Disruptors In 2018


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorUpgradesHealth CarePrice TargetTop StoriesAnalyst RatingsGeneralGary TaylorJPMorgan